Skip to main content
SpringerLink
Log in

STARflo – ein suprachoroidales Drainageimplantat in der Glaukomchirurgie

STARflo—a suprachoroidal drainage implant in glaucoma surgery

  • Originalien
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Das STARflo-Glaukomdrainageimplantat (Fa. iSTAR Medical, Wavre, Belgien) ermöglicht die Senkung des intraokularen Drucks durch Kammerwasserabfluss in den suprachoroidalen Raum ohne die Ausbildung eines Sickerkissens.

Material und Methoden

Anhand einer Fallserie von 9 Patienten mit medikamentös nicht kontrollierbarem Offenwinkelglaukom wird über die intra- und postoperative Erfahrung mit dem STARflo berichtet. Dargestellt werden das Implantat, die Implantationstechnik sowie klinische Ergebnisse 6 Monate postoperativ.

Ergebnisse

Intraoperativ zeigten sich keine Komplikationen. Postoperative Hypotonien oder höhere Astigmatismen waren transient. Ausgehend von einem präoperativen Mitteldruck von 29,1 ± 6,1 mm Hg unter 2,7 ± 1,1 Medikamenten kam es 6 Monate postoperativ zu einer Drucksenkung auf 16,1 ± 4,1 mm Hg (Druckreduktion um 44,7 %) unter 2,0 ± 0,8 Medikamenten.

Diskussion

Das STARflo-Drainageimplantat ist ein innovatives Verfahren zur intraokularen Drucksenkung bei medikamentös nicht reguliertem Offenwinkelglaukom. Weitere Studien klären derzeit den Langzeiteffekt und notwendige Begleitmedikation.

Abstract

Background

The STARflo Glaucoma Device (iSTAR Medical, Wavre, Belgium) offers a new approach to bleb-free filtering surgery in which the intraocular pressure (IOP) is lowered by supporting outflow of the aqueous humor into the suprachoroidal space.

Materials and methods

On the basis of a case series of 9 patients with open-angle glaucoma (OAG) unmanageable by drug-based treatment, intra- and postoperative experiences with the implant are presented. The implant, the implantation procedure, and the first results 6 months postoperatively are described.

Results

No intraoperative complications were observed. Postoperative complications such as increased astigmatism or ocular hypotony were rare and transient. After 6 months there was an IOP reduction from 29.1 mm Hg ± 6.1 mm Hg with 2.7 ± 1.1 local IOP-lowering medications to 16.1 ± 4.1 mm Hg (IOP reduction of 44.7%) with additional 2.0 ± 0.8 local IOP-lowering medications.

Discussion

The new STARflo Glaucoma Device shows promising results in reducing the IOP of medically uncontrolled OAG. Further investigations concerning the long-time efficacy of the implant and additional IOP-lowering medication are still ongoing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Bill A, Phillips CI (1971) Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res 12(3):275–281

    Article  PubMed  CAS  Google Scholar 

  2. Toris CB, Yablonski ME, Wang YL, Camras CB (1999) Aqueous humor dynamics in the aging human eye. Am J Ophthalmol 127(4):407–412

    Article  PubMed  CAS  Google Scholar 

  3. Weinreb RN (2000) Uveoscleral outflow: the other outflow pathway. J Glaucoma 9(5):343–345

    Article  PubMed  CAS  Google Scholar 

  4. Mosaed S, Minckler DS (2010) Aqueous shunts in the treatment of glaucoma. Expert Rev Med Devices 7(5):661–666

    Article  PubMed  Google Scholar 

  5. Ratner BD, Marshall A., inventors; University of Washington, assignee. Porous biomaterials. United States patent US 7972628 B2. 5 July 2011.

  6. Ratner BD, Marshall A, inventors; University of Washington, assignee. Crosslinked porous biomaterials. United States patent US 8318193. 27 Nov 2012.

  7. Ratner BD, A M, inventors; University of Washington, assignee. Novel porous biomaterials that support vascular ingrowth. European patent EP 1670385. 23 Jan 2013.

  8. Ayyala RS, Michelini-Norris B, Flores A, Haller E, Margo CE (2000) Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol 118(8):1081–1084

    Article  PubMed  CAS  Google Scholar 

  9. Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL et al (2010) Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA 107(34):15211–15216

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM (1998) Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res 40(4):586–597

    Article  PubMed  CAS  Google Scholar 

  11. Marshall.; A. Hydrogels with well-defined pore structure for biomaterials appliactions [PhD dissertation]: University of Washington; 2004.

  12. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC (1995) Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 29(12):1517–1524

    Article  PubMed  CAS  Google Scholar 

  13. Marshall AJ, Alvarez M, Maginness M, inventors; Healionics Corporation, assignee. Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same. United States patent US 2011/0257623 A1. 20 Oct 2011.

  14. Pourjavan S, Pourjavan S, Collignon NJM, De Groot V, Eiferman RA, Marshall AJ, Roy CJ (2014) STARfloTM: a suprachoroidal drainage implant made from STAR biomaterial. In: Samples JR, Ahmed IIK (Hrsg) Surgical innovations in glaucoma. Springer, New York, S 235–251

    Chapter  Google Scholar 

  15. Roberts S, Woods C (2008) Preliminary report: effect of a novel porous implant in refractory glaucomatous dogs. Vet Ophthalmol 423

  16. Cseke I, Vamosi P, Bausz M (2016) Starflo glaucoma implant: early experience in Hungary. Rom J Ophthalmol 60(1):14–17

    PubMed  Google Scholar 

  17. Rekas M, Pawlik B, Grala B, Kozlowski W (2013) Clinical and morphological evaluation of gold micro shunt after unsuccessful surgical treatment of patients with primary open-angle glaucoma. Eye (Lond) 27(10):1214–1217

    Article  CAS  Google Scholar 

  18. Agnifili L, Costagliola C, Figus M, Iezzi G, Piattelli A, Carpineto P et al (2012) Histological findings of failed gold micro shunts in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 250(1):143–149

    Article  PubMed  Google Scholar 

  19. Kammer JA, Mundy KM (2015) Suprachoroidal devices in glaucoma surgery. Middle East Afr J Ophthalmol 22(1):45–52

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hueber A, Roters S, Jordan JF, Konen W (2013) Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol 13:35

    Article  PubMed  PubMed Central  Google Scholar 

  21. Figus M, Lazzeri S, Fogagnolo P, Iester M, Martinelli P, Nardi M (2011) Supraciliary shunt in refractory glaucoma. Br J Ophthalmol 95(11):1537–1541

    Article  PubMed  Google Scholar 

  22. Vold SA II, Craven ER, Mattox C, Stamper R, Packer M et al (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123(10):2103–2112

    Article  PubMed  Google Scholar 

  23. Millar JC, Phan TN, Pang IH, Clark AF (2015) Strain and age effects on aqueous humor dynamics in the mouse. Invest Ophthalmol Vis Sci 56(10):5764–5776

    Article  PubMed  Google Scholar 

  24. Alm A, Nilsson SF (2009) Uveoscleral outflow – a review. Exp Eye Res 88(4):760–768

    Article  PubMed  CAS  Google Scholar 

  25. Gabelt BT, Kaufman PL (2005) Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 24(5):612–637

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität, Mathildenstr. 8, 80336, München, Deutschland

    S. König &  C. W. Hirneiß

Authors
  1. S. König
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. W. Hirneiß
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. W. Hirneiß.

Ethics declarations

Interessenkonflikt

S. König und C. W. Hirneiß geben an, dass kein Interessenkonflikt besteht.

Alle beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zuständigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patienten liegt eine Einverständniserklärung vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

König, S., Hirneiß, C.W. STARflo – ein suprachoroidales Drainageimplantat in der Glaukomchirurgie. Ophthalmologe 115, 670–675 (2018). https://doi.org/10.1007/s00347-017-0565-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-017-0565-0

Schlüsselwörter

Keywords

Search

Navigation